Ribavirin acts via multiple pathways in inhibition of leukemic cell proliferation

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 1971-1980

  Kökény, Szabolcs ^a   Papp, János ^a   Weber, George ^b   Vaszkó, Tibor ^a   Carmona Saez, Pedro ^c   Oláh, Edith ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Integromics   (Spain)

Author keywords

Apoptosis; Cell differentiation; Gene expression profiling; Inositide 5 monophosphate dehydrogenase (IMPDH); K562; Leukemia; Ribavirin

Indexed keywords

PURINE; RIBAVIRIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRAIN K 562; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLOGY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; ERYTHROID CELL; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL; OVARY CANCER; PRIORITY JOURNAL; PURINE SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSLATION INITIATION; UPREGULATION;

ANTIMETABOLITES; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 67650882747     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT and Robins RK: Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4- triazole-3-carboxamide. Science 177: 705-706, 1972.
2. Weber G, Shen F, Yang H, Prajda N and Li W: Amplification of signal transduction capacity and down-regulation by drugs. Adv Enzyme Regul 39: 51-66, 1999. (Pubitemid 129682488)
3. Yamada Y, Natsumeda Y and Weber G: Action of the active metabolites of tiazofurin and Ribavirin on purified IMP dehydrogenase. Biochemistry 27: 2193-2196, 1988. (Pubitemid 18102054)
4. Weber G: Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res 43: 3466-3492, 1983.
5. Jackson RC, Weber G and Morris HP: IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 256: 331-333, 1975.
6. Konno Y, Natsumeda Y, Nagai M, Yamaji Y, Ohno S, Suzuki K and Weber G: Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J Biol Chem 266: 506-509, 1991. (Pubitemid 21906152)
7. Nagai M, Natsumeda Y, Konno Y, Hoffman R, Irino S and Weber G: Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res 51: 3886-3890, 1991.
8. Nagai M, Natsumeda Y and Weber G: Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res 52: 258-261, 1992.
9. Li W, Shen F and Weber G: Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells. Oncology Res 11: 243-247, 1999.
10. Weber G, Shen F, Prajda N, Yang H, Li W, Yeh A, Csokay B, Olah E and Look KY: Regulation of the signal transduction program by drugs. Adv Enzyme Regul 37: 35-55, 1997. (Pubitemid 27371554)
11. Weber G, Shen DF, Li W, Yang H, Look KY, Abonyi M and Prajda N: Signal transduction and biochemical targeting of ovarian carcinoma. Eur J Gynaecol Oncol 3: 231-236, 2000. (Pubitemid 30468310)
12. Olah E, Natsumeda Y, Ikegami T, Kote Z, Horanyi M, Szelenyi J, Paulik E, Kremmer T, Hollan SR, Sugar J and Weber G: Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc Natl Acad Sci USA 85: 6533-6537, 1988. (Pubitemid 18219198)
13. Olah E, Ezer R, Giaretti W and Eble J: Metabolic control of oncogene expression. Biochem Soc Trans 18: 72-74, 1989.
14. Olah E, Kokeny Sz, Papp J, Bozsik A and Keszei M: Modulation of cancer pathways by inhibitors of guanylate metabolism. Adv Enzyme Regul 46: 176-190, 2006. (Pubitemid 44301349)
15. Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G and Hoffman R: Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity. Cancer Res 49: 3696-3701, 1989. (Pubitemid 19178199)
16. Tricot G, Jayaram HN, Weber G and Hoffman R: Tiazofurin: biological effects and clinical uses. Intl J Cell Cloning 8: 161-170, 1990. (Pubitemid 20203621)
17. Weber G, Nagai M, Natsumeda Y, Eble JN, Jayaram HN, Paulik E, Zhen WN, Hoffman R and Tricot G: Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient. Cancer Commun 3: 61-66, 1991.
18. Tricot G and Weber G: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with tiazofurin, a selective locker of inosine 50-phosphate dehydrogenase activity. Anticancer Res 16: 3341-3347, 1996. (Pubitemid 27085079)
19. Taylor MW, Grosse WM, Schaley JE, Sanda C, Wu X, Chien SC, Smith F, Wu TG, Stephens M, Ferris MW, McClintick JN, Jerome RE and Edenberg HJ: Global effect of PEG-IFN-alpha and Ribavirin on gene expression in PBMC in vitro. J Interferon Cytokine Res 24: 107-118, 2004. (Pubitemid 38253638)
20. Kentsis A, Topisirovic I, Culjkovic B, Shao L and Borden KL: Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci USA 101: 18105-18110, 2004. (Pubitemid 40054081)
21. Kentsis A, Volpon L, Topisirovic I, Soll CE, Culjkovic B, Shao L and Borden KL: Further evidence that Ribavirin interacts with eIF4E. RNA 11: 1762-1766, 2005. (Pubitemid 41720025)
22. Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA and Weber G: Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Res 16: 2469-2477, 1996. (Pubitemid 26388203)
23. Kerr JFR, Winterford CM and Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
24. DDCT Method, Methods 25: 402-408, 2001. (Pubitemid 34164012)
25. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muraganujan A, Doremieux O, Campbell MJ, Kitano H and Thomas PD: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33: D284-288, 2005. (Pubitemid 40207879)
26. Joachimiak MP, Weissman JL and May BCH: JColorGrid: software for the visualization of biological measurements, BMC Bioinformatics 7: 225, 2006. (Pubitemid 43918502)
27. Abramoff MD, Magelhaes PJ and Ram SJ: Image Processing with ImageJ. Biophotonics International 11: 36-42, 2004.
28. Schlosser SF, Schuler M, Berg CP, Lauber K, Schulze-Osthoff K, Schmahl FW and Wesselborg S: Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells. Antimicrob Agent Chemother 47: 1912-1921, 2003. (Pubitemid 36637814)
29. Olah E, Kote Z, Natsumeda Y, Yamaji Y, Jarai G, Lapis E, Financsek I and Weber G: Down-regulation of MYC and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochem Biophys 11: 107-117, 1990.
30. Floryk D and Huberman E: Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-kappaB activity. Cancer Res 65: 11588-11596, 2005. (Pubitemid 41821718)
31. Cocco L, Capitani S, Maraldi NM, Mazzotti G, Barnabei O, Gilmour RS and Manzoli FA: Inositol lipid cycle and autonomous nuclear signalling. Adv Enzyme Regul 36: 101-114, 1996. (Pubitemid 27065707)
32. Carnero A and Beach DH: Absence of p21WAF1 cooperates with MYC in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene 23: 6006-6011, 2004. (Pubitemid 39093546)
33. Shachaf CM and Felsher DW: Rehabilitation of cancer through oncogene inactivation. Trends Mol Med 11: 316-321, 2005. (Pubitemid 40984713)
34. Weber G, Shen F, Orban TI, Kokeny S and Olah E: Targeting signal transduction. Advan Enzyme Regul 43: 47-56, 2003.